Acurion, a precision oncology technology company developing AI-driven approaches to cancer biomarker detection, today announced that Co-Founder and Board Member Magda Marquet, Ph.D., will participate ...

Leaders from The US Oncology Network and McKesson discuss how technology can enhance precision medicine and improve patient access to cutting-edge cancer treatments. Twenty-five years have passed ...

At the April 30 events, oncology leaders and OpenAI unveiled new approaches aimed at transforming specialist care. Seungjean Chai, MD, emphasized patient-centered design, clinical guidelines, and ...

SAN DIEGO, April 2, 2026 /PRNewswire/ -- Acurion, a precision oncology technology company advancing AI-driven cancer biomarker detection through its OncoGaze™ platform, today announced the closing of ...

CLEVELAND, Ohio – Akesis, Inc. (Akesis), a leader in cutting-edge radiation oncology technology, has formed a groundbreaking collaboration with University Hospitals Seidman Cancer Center, a nationally ...

CHICAGO, IL, UNITED STATES, April 15, 2026 /EINPresswire.com/ — NovaScan, Inc., a clinical-stage oncology technology company developing point-of-care cancer ...

Acurion, a precision oncology technology company developing AI-driven approaches to cancer biomarker detection, today announced that Co-Founder ...